Processing of CD109 by furin and its role in the regulation of TGF-Β signaling

Oncogene

Volumn 29, Issue 15, 2010, Pages 2181-2191

  Hagiwara, S ^a   Murakumo, Y ^a   Mii, S ^a   Shigetomi, T ^a   Yamamoto, N ^a   Furue, H ^a   Ueda, M ^a   Takahashi, M ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD109; Cell proliferation; Furin; Processing; TGF b

Indexed keywords

CD109 ANTIGEN; FURIN; GLYCOPROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTIBODIES; ANTIGENS, CD; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CULTURE MEDIA; EPITOPES; FURIN; GLYCOPROTEINS; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; MOLECULAR WEIGHT; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SMAD PROTEINS; SOLUBILITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77951057345     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.506     Document Type: Article

References (40)

1. Arnold JN, Wallis R, Willis AC, Harvey DJ, Royle L, Dwek RA et al. (2006). Interaction of mannan binding lectin with a2 macroglobulin via exposed oligomannose glycans. A conversed feature of the thiol ester protein family. J Biol Chem 281: 6955-6963.
2. Bierie B, Moses HL. (2006). Tumour microenvironment: TGFb: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520.
3. Dennler S, Goumans MJ, Ten Dijke P. (2002). Transforming growth factor beta signal transduction. J Leukoc Biol 71: 731-740.
4. Derynck R, Akhurst RJ, Balmain A. (2001). TGF-b signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129.
5. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. (1995). Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270: 10618-10624.
6. Finnson KW, Tam BY, Liu K, Marcoux A, Lepage P, Roy S et al. (2006). Identification of CD109 as part of the TGF-b receptor system in human keratinocytes. FASEB J 20: 1525-1527.
7. Garcia M, Mirre C, Quaroni A, Reggio H, Le Bivic A. (1993). GPI-anchored proteins associate to form microdomains during their intracellular transport in Caco-2 cells. J Cell Sci 104: 1281-1290.
8. Gentry LE, Nash BW. (1990). The pro-domain of pre-pro-transform-ing growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 29: 6851-6857.
9. Giesert C, Marxer A, Sutherland DR, Schuh AC, Kanz L, Burring HJ. (2003). Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34-hematopoietic and mesenchymal stem cell subsets. Ann NY Acad Sci 996: 227-230.
10. Guarnaccia SP, Shaper JH, Schnaar RL. (1983). Tunicamycin inhibits ganglioside biosynthesis in neuronal cells. Proc Natl Acad Sci USA 80: 1551-1555.
11. Hagiwara S, Murakumo Y, Sato T, Shigetomi T, Mitsudo K, Tohnai I et al. (2008). Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity. Cancer Sci 99: 1916-1923.
12. Haregewoin A, Solomon K, Hom RC, Soman G, Bergelson JM, Bhan AK et al. (1994). Cellular expression of a GPI-linked T cell activation protein. Cell Immunol 156: 357-370.
13. Hasegawa M, Hagiwara S, Sato T, Jijiwa M, Murakumo Y, Maeda M et al. (2007). CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells. Pathol Int 57: 245-250.
14. Hasegawa M, Moritani S, Murakumo Y, Sato T, Hagiwara S, Suzuki C et al. (2008). CD109 expression in basal-like breast carcinoma. Pathol Int 58: 288-294.
15. Hashimoto M, Ichihara M, Watanabe T, Kawai K, Koshikawa K, Yuasa N et al. (2004). Expression of CD109 in human cancer. Oncogene 23: 3716-13120
16. Jakowlew SB. (2006). Transforming growth factor-b in cancer and metastasis. Cancer Metastasis Rev 25: 435-457.
17. a/b alloantigen system on human platelets. Blood 75: 2172-2176.
18. Leivonen SK, Kahari VM. (2007). Transforming growth factor-b signaling in cancer invasion and metastasis. Int J Cancer 121: 2119-2124.
19. Lin M, Sutherland DR, Horsfall W, Totty N, Yeo E, Nayar R et al. (2002). Cell surface antigen CD109 is a novel member of the a2 macroglobulin/C3, C4, C5 family of thioester-containing proteins. Blood 99: 1683-1691.
20. Massague J, Seoane J, Wotton D. (2005). Smad transcription factors. Genes Dev 19: 2783-2810.
21. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. (1992). Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267: 16396-16402.
22. Moustakas A, Pardali K, Gaal A, Heldin CH. (2002). Mechanisms of TGF-bsignaling in regulation of cell growth and differentiation. Immunol Lett 82: 85-91.
23. Murray LJ, Bruno E, Uchida N, Hoffman R, Nayar R, Yeo EL et al. (1999). CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells. Exp Hematol 27: 1282-1294.
24. Nakayama K. (1997). Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327: 625-635.
25. Ouweland AM, Duijnhoven HL, Keizer GD, Dorssers LC, Ven WJ. (1990). Structural homology between the human fur gene product and the subtilisin-like protease encoded by yeast KEX2. Nucleic Acids Res 18: 664.
26. Pardali K, Moustakas A. (2007). Actions of TGF-b as tumor suppressor and pro-metastatic factor in human cancer. Biochim et Biophysi Acta 1775: 21-62.
27. Rouille Y, Duguay SJ, Lund K, Furuta M, Gong Q, Lipkind G et al. (1995). Proteolytic processing mechanism in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front Neuroendocrinol 16: 322-361.
28. Sato T, Murakumo Y, Hagiwara S, Jijiwa M, Suzuki C, Yatabe Y et al. (2007). High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Pathol Int 57: 719-724.
29. Shi Y, Massague J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
30. Steiner DF. (1998). The proprotein convertases. Curr Opin Chem Biol 2: 31-39.
31. Struck DK, Lennarz WJ. (1977). Evidence for the participation of saccharide-lipids in the synthesis of the oligosaccharide chain of ovalbumin. J Biol Chem 252: 1007-1013.
32. Sutherland DR, Yeo E, Ryan A, Mills GB, Bailey D, Baker MA. (1991). Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets. Blood 77: 84-93.
33. Takatsuki A, Arima K, Tamura G. (1971). Tunicamycin. a new antibiotic. I. Isolation and characterization of tunicamycin. J Antibiot 24: 215-223.
34. Tam BY, Finnson KW, Philip A. (2003). Glycosylphosphatidylinosi-tol- anchored proteins regulate transforming growth factor-b signaling in human keratinocytes. J Biol Chem 278: 49610-49617.
35. Thomas G. (2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3: 753-766.
36. Waechter CJ, Harford JB. (1977). Evidence for the enzymatic transfer of N-acetylglucosamine from UDP-N-acetylglucosamine into do-lichol derivative and glycoproteins by calf brain membranes. Arch Biochem Biophys 181: 185-198.
37. Wakefield LM, Roberts AB. (2002). TGF-b signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
38. Wang X, Sun W, Bai J, Ma L, Yu Y, Geng J et al. (2009). Growth inhibition induced by transforming growth factor-b1 in human oral squamous cell carcinoma. Mol Biol Rep 36: 861-869.
39. Xu X, Brodie SG, Yang X, Im YH, Parks WT, Chen L et al. (2000). Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19: 1868-1874.
40. Zhang JM, Hashimoto M, Kawai K, Murakumo Y, Sato T, Ichihara M et al. (2005). CD109 expression in squamous cell carcinoma of the uterine cervix. Pathol Int 55: 165-169. (Pubitemid 40676925)